This AI method could turbocharge the hunt for new medicines
An AI model trained on cellular genomic perturbation data can accelerate drug discovery by predicting compound effects across cell types, reducing costly large-scale screens.
AMPLY Discovery raised $1.75M to develop innovative AI-driven drug discovery therapies targeting cancers and drug-resistant infections in preclinical stages.